Findings reveal zero pretreatment HIV-1 resistance to integrase strand transfer inhibitors in Benin, indicating effective use as first-line treatment.
Prevalence of pretreatment HIV-1 resistance to integrase is zero. Study reinforces the WHO vision of improving patient outcomes by introducing INSTIs as first-line treatment regimens.
No takes yet. Share an insight, caveat, or question.
TCHIAKPE et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: